Lupin’s Stock Falls After U.S. FDA Issues Warning Letter To Mandideep Plant
Capsules fall into a collection bin at a drug manufacturing plant in Goa (Photographer: Dhiraj Singh/Bloomberg)

Lupin’s Stock Falls After U.S. FDA Issues Warning Letter To Mandideep Plant

Lupin Ltd. said the U.S. drug regulator has issued a warning letter to its plant in Mandideep, Madhya Pradesh over manufacturing practices, a move that may delay future approvals for exporting to i...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.